Literature DB >> 3158002

Docosahexaenoic acid (C22:6 omega 3) and linoleic acid are anti-aggregatory, and alter arachidonic acid metabolism in human platelets.

K C Srivastava.   

Abstract

Effects of various concentrations (12.5-500 uM) of linoleic acid and docosahexaenoic acid (C22:6 omega 3)(sod. salt) were examined on the platelet metabolism of labelled arachidonate (AA) under two different incubation conditions. In the first platelets were pretreated with either fatty acid prior to incubation with labelled AA; and in the second incubation platelets were incubated with a mixture containing a fatty acid (linoleic acid or DHA) and labelled AA. At all concentrations the two fatty acids reduced the formation of TxB2. At lower concentrations (up to 200 uM) the fatty acids inhibited platelet cyclooxygenase as shown by a reduced formation of prostaglandins (PGs) and TxB2. At higher concentrations (400 and 500 uM), however, the fatty acids behaved differently. Although TxB2 formation was reduced, there was observed an increased formation of PGs. In DHA pretreated platelets only PGE2 increased (to double control values). Platelets pretreated with linoleic acid produced increased amounts of all PGs (PGF2 alpha, PGE2, PGD2), and this effect was greatest for PGE2 which increased by 5-6 fold of control values. DHA showed a dose-dependent inhibition of platelet aggregation induced by arachidonate, epinephrine and collagen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158002     DOI: 10.1016/0262-1746(85)90121-0

Source DB:  PubMed          Journal:  Prostaglandins Leukot Med        ISSN: 0262-1746


  5 in total

Review 1.  12-lipoxygenase: a potential target for novel anti-platelet therapeutics.

Authors:  Jennifer Yeung; Michael Holinstat
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2011-07-01

2.  Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity.

Authors:  D C Gaudette; B J Holub
Journal:  Lipids       Date:  1990-03       Impact factor: 1.880

3.  Eskimo plasma constituents, dihomo-gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid inhibit the release of atherogenic mitogens.

Authors:  D L Smith; A L Willis; N Nguyen; D Conner; S Zahedi; J Fulks
Journal:  Lipids       Date:  1989-01       Impact factor: 1.880

4.  Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality.

Authors:  James J DiNicolantonio; James H O'Keefe; Mark F McCarty
Journal:  Open Heart       Date:  2017-09-02

5.  Synergistic platelet inhibition between Omega-3 and acetylsalicylic acid dose titration; an observational study.

Authors:  Harald Bagger; Mattias Hansson; Thomas Kander; Ulf Schött
Journal:  BMC Complement Med Ther       Date:  2020-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.